| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 8.06e-07 | 11 | 35 | 3 | GO:0098973 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 8.44e-07 | 42 | 35 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 2.36e-05 | 32 | 35 | 3 | GO:0099186 | |
| GeneOntologyMolecularFunction | kinase binding | 1.26e-03 | 969 | 35 | 7 | GO:0019900 | |
| GeneOntologyMolecularFunction | ephrin receptor binding | 1.43e-03 | 32 | 35 | 2 | GO:0046875 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.52e-03 | 130 | 35 | 3 | GO:0005200 | |
| GeneOntologyMolecularFunction | translation initiation factor binding | 2.12e-03 | 39 | 35 | 2 | GO:0031369 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 1.78e-05 | 31 | 34 | 3 | GO:0098974 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 2.58e-05 | 35 | 34 | 3 | GO:0099188 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 2.25e-05 | 32 | 36 | 3 | GO:0043189 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 2.25e-05 | 32 | 36 | 3 | GO:0035267 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 6.33e-05 | 45 | 36 | 3 | GO:1902562 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 5.65e-04 | 94 | 36 | 3 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 7.58e-04 | 104 | 36 | 3 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 8.69e-04 | 109 | 36 | 3 | GO:1902493 | |
| GeneOntologyCellularComponent | actin filament | 2.01e-03 | 146 | 36 | 3 | GO:0005884 | |
| MousePheno | decreased testis weight | 2.11e-06 | 370 | 16 | 6 | MP:0004852 | |
| MousePheno | abnormal testis weight | 2.91e-06 | 391 | 16 | 6 | MP:0004850 | |
| MousePheno | abnormal germ cell physiology | 9.00e-06 | 267 | 16 | 5 | MP:0020363 | |
| MousePheno | small sperm head | 8.05e-05 | 12 | 16 | 2 | MP:0009235 | |
| MousePheno | abnormal cilium morphology | 9.17e-05 | 433 | 16 | 5 | MP:0013202 | |
| MousePheno | abnormal male germ cell physiology | 1.40e-04 | 244 | 16 | 4 | MP:0020362 | |
| MousePheno | small testis | 1.97e-04 | 823 | 16 | 6 | MP:0001147 | |
| MousePheno | small gonad | 2.92e-04 | 885 | 16 | 6 | MP:0001116 | |
| MousePheno | abnormal primary sex determination | 3.22e-04 | 901 | 16 | 6 | MP:0002211 | |
| MousePheno | abnormal testis size | 3.51e-04 | 915 | 16 | 6 | MP:0004849 | |
| MousePheno | abnormal sex determination | 4.18e-04 | 945 | 16 | 6 | MP:0002210 | |
| MousePheno | abnormal sperm number | 5.05e-04 | 624 | 16 | 5 | MP:0002673 | |
| MousePheno | decreased male germ cell number | 5.67e-04 | 640 | 16 | 5 | MP:0004901 | |
| MousePheno | abnormal seminiferous tubule morphology | 7.33e-04 | 377 | 16 | 4 | MP:0002216 | |
| MousePheno | decreased germ cell number | 7.84e-04 | 687 | 16 | 5 | MP:0002209 | |
| MousePheno | abnormal parietal lobe morphology | 7.99e-04 | 37 | 16 | 2 | MP:0000794 | |
| MousePheno | abnormal testis morphology | 8.59e-04 | 1081 | 16 | 6 | MP:0001146 | |
| MousePheno | teratozoospermia | 9.85e-04 | 408 | 16 | 4 | MP:0005578 | |
| MousePheno | increased male germ cell apoptosis | 1.20e-03 | 189 | 16 | 3 | MP:0014052 | |
| MousePheno | abnormal neocortex morphology | 1.34e-03 | 48 | 16 | 2 | MP:0008547 | |
| MousePheno | abnormal gametes | 1.43e-03 | 785 | 16 | 5 | MP:0001124 | |
| MousePheno | abnormal neuronal precursor cell number | 1.58e-03 | 52 | 16 | 2 | MP:0004979 | |
| MousePheno | abnormal circulating glycerol level | 1.76e-03 | 55 | 16 | 2 | MP:0011973 | |
| MousePheno | kinked sperm flagellum | 1.82e-03 | 56 | 16 | 2 | MP:0009237 | |
| MousePheno | abnormal cerebellar foliation | 1.96e-03 | 58 | 16 | 2 | MP:0000857 | |
| MousePheno | reduced fertility | 1.98e-03 | 844 | 16 | 5 | MP:0001921 | |
| MousePheno | abnormal gallbladder morphology | 2.09e-03 | 60 | 16 | 2 | MP:0005084 | |
| MousePheno | abnormal male germ cell morphology | 2.14e-03 | 859 | 16 | 5 | MP:0006362 | |
| MousePheno | abnormal male reproductive gland morphology | 2.17e-03 | 1290 | 16 | 6 | MP:0013325 | |
| MousePheno | abnormal male germ cell apoptosis | 2.26e-03 | 236 | 16 | 3 | MP:0008280 | |
| MousePheno | abnormal glycerol level | 2.30e-03 | 63 | 16 | 2 | MP:0003439 | |
| MousePheno | abnormal male reproductive system physiology | 2.53e-03 | 1329 | 16 | 6 | MP:0003698 | |
| MousePheno | abnormal cerebellum lobule morphology | 2.76e-03 | 69 | 16 | 2 | MP:0009964 | |
| MousePheno | abnormal spermatogenesis | 2.76e-03 | 910 | 16 | 5 | MP:0001156 | |
| MousePheno | abnormal nonmotile primary cilium morphology | 2.83e-03 | 70 | 16 | 2 | MP:0013205 | |
| MousePheno | abnormal internal male genitalia morphology | 3.21e-03 | 1392 | 16 | 6 | MP:0009205 | |
| MousePheno | abnormal germ cell morphology | 3.27e-03 | 946 | 16 | 5 | MP:0002208 | |
| MousePheno | abnormal foam cell morphology | 3.39e-03 | 954 | 16 | 5 | MP:0009840 | |
| MousePheno | abnormal male genitalia morphology | 3.48e-03 | 1415 | 16 | 6 | MP:0009198 | |
| MousePheno | abnormal male reproductive system morphology | 3.48e-03 | 1415 | 16 | 6 | MP:0001145 | |
| Domain | ANK | 4.85e-10 | 251 | 34 | 9 | SM00248 | |
| Domain | ANK_REPEAT | 5.20e-10 | 253 | 34 | 9 | PS50088 | |
| Domain | ANK_REP_REGION | 5.39e-10 | 254 | 34 | 9 | PS50297 | |
| Domain | Ankyrin_rpt | 7.08e-10 | 262 | 34 | 9 | IPR002110 | |
| Domain | Ank_2 | 3.80e-09 | 215 | 34 | 8 | PF12796 | |
| Domain | Ank | 6.03e-09 | 228 | 34 | 8 | PF00023 | |
| Domain | - | 1.16e-08 | 248 | 34 | 8 | 1.25.40.20 | |
| Domain | Ankyrin_rpt-contain_dom | 1.40e-08 | 254 | 34 | 8 | IPR020683 | |
| Domain | Actin_CS | 3.04e-06 | 16 | 34 | 3 | IPR004001 | |
| Domain | ACTINS_2 | 3.68e-06 | 17 | 34 | 3 | PS00432 | |
| Domain | Actin/actin-like_CS | 4.41e-06 | 18 | 34 | 3 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 5.24e-06 | 19 | 34 | 3 | PS01132 | |
| Domain | Actin | 2.39e-05 | 31 | 34 | 3 | IPR004000 | |
| Domain | Actin | 2.39e-05 | 31 | 34 | 3 | PF00022 | |
| Domain | ACTIN | 2.39e-05 | 31 | 34 | 3 | SM00268 | |
| Domain | ARM-like | 1.28e-02 | 270 | 34 | 3 | IPR011989 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 2.65e-12 | 15 | 36 | 5 | 16824795 | |
| Pubmed | 3.38e-11 | 7 | 36 | 4 | 15276201 | ||
| Pubmed | 1.21e-10 | 9 | 36 | 4 | 16364570 | ||
| Pubmed | 3.25e-10 | 163 | 36 | 7 | 24316575 | ||
| Pubmed | 2.03e-08 | 6 | 36 | 3 | 17171436 | ||
| Pubmed | 5.68e-08 | 8 | 36 | 3 | 12475935 | ||
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 1.04e-06 | 2 | 36 | 2 | 19669888 | |
| Pubmed | 1.38e-06 | 1442 | 36 | 10 | 35575683 | ||
| Pubmed | 3.00e-06 | 96 | 36 | 4 | 23580065 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 11959995 | ||
| Pubmed | Evolution and expression of chimeric POTE-actin genes in the human genome. | 3.12e-06 | 3 | 36 | 2 | 17101985 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 17342726 | ||
| Pubmed | 1.24e-05 | 506 | 36 | 6 | 30890647 | ||
| Pubmed | 1.71e-05 | 149 | 36 | 4 | 22664934 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 2.88e-05 | 588 | 36 | 6 | 38580884 | |
| Pubmed | 1.63e-04 | 102 | 36 | 3 | 26584622 | ||
| Pubmed | 1.77e-04 | 513 | 36 | 5 | 25798074 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 2.20e-04 | 288 | 36 | 4 | 31501420 | |
| Pubmed | Proteomic characterization of the human centrosome by protein correlation profiling. | 3.33e-04 | 26 | 36 | 2 | 14654843 | |
| Pubmed | 7.52e-04 | 1497 | 36 | 7 | 31527615 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 7.83e-04 | 1082 | 36 | 6 | 38697112 | |
| Pubmed | 7.91e-04 | 1084 | 36 | 6 | 11544199 | ||
| Pubmed | 8.86e-04 | 417 | 36 | 4 | 36537216 | ||
| Pubmed | 9.00e-04 | 733 | 36 | 5 | 34672954 | ||
| Pubmed | 9.50e-04 | 425 | 36 | 4 | 21081503 | ||
| Interaction | POTEC interactions | 1.49e-11 | 13 | 35 | 5 | int:POTEC | |
| Interaction | POTED interactions | 1.92e-08 | 4 | 35 | 3 | int:POTED | |
| Interaction | POTEB3 interactions | 3.84e-07 | 35 | 35 | 4 | int:POTEB3 | |
| Interaction | POTEG interactions | 1.04e-06 | 12 | 35 | 3 | int:POTEG | |
| Interaction | UBE2O interactions | 4.94e-05 | 790 | 35 | 8 | int:UBE2O | |
| Interaction | FBXO42 interactions | 7.99e-05 | 259 | 35 | 5 | int:FBXO42 | |
| Interaction | ACTG2 interactions | 8.37e-05 | 49 | 35 | 3 | int:ACTG2 | |
| Interaction | UTP3 interactions | 1.54e-04 | 157 | 35 | 4 | int:UTP3 | |
| Interaction | ATPSCKMT interactions | 1.60e-04 | 11 | 35 | 2 | int:ATPSCKMT | |
| Interaction | ACTC1 interactions | 1.61e-04 | 694 | 35 | 7 | int:ACTC1 | |
| Interaction | NDC80 interactions | 1.91e-04 | 312 | 35 | 5 | int:NDC80 | |
| Cytoband | 2q21.1 | 1.33e-05 | 58 | 36 | 3 | 2q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q21 | 2.30e-04 | 151 | 36 | 3 | chr2q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q32 | 4.03e-03 | 120 | 36 | 2 | chr4q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20p12 | 4.03e-03 | 120 | 36 | 2 | chr20p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q22 | 5.06e-03 | 135 | 36 | 2 | chr3q22 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 4.35e-19 | 13 | 18 | 7 | 685 | |
| GeneFamily | Ankyrin repeat domain containing | 3.58e-11 | 242 | 18 | 8 | 403 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.75e-02 | 206 | 18 | 2 | 682 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | 1.01e-06 | 584 | 36 | 8 | MM1080 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.07e-05 | 311 | 35 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | 4.05e-05 | 1060 | 35 | 9 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 4.89e-05 | 831 | 35 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_200 | 1.32e-04 | 159 | 35 | 4 | gudmap_developingGonad_e14.5_ testes_200 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | 1.46e-04 | 1252 | 35 | 9 | facebase_RNAseq_e10.5_MaxArch_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 1.65e-04 | 989 | 35 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.45e-04 | 74 | 35 | 3 | gudmap_developingGonad_e14.5_ testes_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 2.72e-04 | 192 | 35 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | 3.64e-04 | 1414 | 35 | 9 | facebase_RNAseq_e10.5_Emin_MedNas_2500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.69e-04 | 85 | 35 | 3 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k1_1000 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.08e-10 | 197 | 36 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-11|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.99e-07 | 63 | 36 | 4 | d7dc1356a60cb527fe668328d5375f352239d911 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-9|TCGA-Breast / Sample_Type by Project: Shred V9 | 8.40e-07 | 90 | 36 | 4 | 96e836c7a1df279ac812b7c3aa75e6b81b614244 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic-platelet|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.32e-05 | 180 | 36 | 4 | beb4d777e0c5fa0a59672dbc3dbb7732498605ff | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.32e-05 | 180 | 36 | 4 | fb3d549c2a69b2157a486786ddd775ca16699ed0 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-05 | 182 | 36 | 4 | b1e66ccd5f33b4801f1cafddf97f5fc0c6dba8d1 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 186 | 36 | 4 | a1ab273b01971d6a892912560d387685dd657179 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 187 | 36 | 4 | ef3c85c01bc3da408ae288b6e3096ad888a12e63 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.77e-05 | 194 | 36 | 4 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.92e-05 | 198 | 36 | 4 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.96e-05 | 199 | 36 | 4 | 53b3d35767889a152f1f38e8f6f0ba8f7a7690f2 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.79e-04 | 136 | 36 | 3 | 27a41463e6f16deb5b1d4f17fefded9959038c07 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.79e-04 | 136 | 36 | 3 | 88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11 | |
| ToppCell | normal_Lung-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 1.95e-04 | 140 | 36 | 3 | 3f003320d797f18d2dfc38eab7f094f75027958e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-04 | 149 | 36 | 3 | a6406c4c9404271a2f4c615c6cd3265b2d759b12 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.58e-04 | 154 | 36 | 3 | ec920cae12ea1d14b6c973f6e903f895f80e3c50 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Naive_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 2.63e-04 | 155 | 36 | 3 | 1020da8a2c30384d962fa204a030299fdfcbbf98 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.84e-04 | 159 | 36 | 3 | 2233fee5dcdb6c7dee5b1bd8efbc07d86b339927 | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-CD8_TCM|ICU-NoSEP / Disease, Lineage and Cell Type | 2.89e-04 | 160 | 36 | 3 | a1bf6ed365cbc1ddb57c132a42dbe6485d45f544 | |
| ToppCell | severe_influenza-CD8+_T_naive|severe_influenza / disease group, cell group and cell class (v2) | 2.94e-04 | 161 | 36 | 3 | 82196139cdbbd70a36957a87bc9ac6d02575da3f | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-04 | 161 | 36 | 3 | 22fea192cd5f6d3544533d8b10e1d74dfedf0f05 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.16e-04 | 165 | 36 | 3 | a5c3af634d2698f9a01cf074791756b7669f9fff | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.16e-04 | 165 | 36 | 3 | 4297588f809e8a8275ab1a6ed99daac7ad93bd61 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 3.22e-04 | 166 | 36 | 3 | 773673a5d0430640439845b264740bfbbdad0cb2 | |
| ToppCell | Dividing_Macrophages-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 3.22e-04 | 166 | 36 | 3 | ea95b94ccc2ac67df741b30c27f4ae698925875f | |
| ToppCell | Dividing_Macrophages-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 3.39e-04 | 169 | 36 | 3 | eb0c993ef2eea73bc4881182520922ce9ae9368f | |
| ToppCell | Dividing_Macrophages-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 3.39e-04 | 169 | 36 | 3 | bc859a103cad567caf50c3c3882d2d2017807c73 | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.45e-04 | 170 | 36 | 3 | 5319f73cff64f2bb67472c7156ee1d0f006c6fc0 | |
| ToppCell | TCGA-Cervix|World / Sample_Type by Project: Shred V9 | 3.45e-04 | 170 | 36 | 3 | a6cbe253bc60f5d5cb361c7e85ed9928a3155ec8 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.51e-04 | 171 | 36 | 3 | 2991096336eea87740708360e34f84a00cb2eff2 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.57e-04 | 172 | 36 | 3 | c74c1d47b133eb5d0f762a06e421252a76b4672b | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.57e-04 | 172 | 36 | 3 | 6fcc16f1067672967ecbcdfdc727649ae9891dd9 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.57e-04 | 172 | 36 | 3 | 7f3d0ef18f5df1ed80498d435b0378ca398c0b88 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.70e-04 | 174 | 36 | 3 | 46cbb462173a684ceb9e680f9259dc3b133763f7 | |
| ToppCell | Dividing_Macrophages-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 3.76e-04 | 175 | 36 | 3 | 0a8bf455babb3271aa00642199fb58b0b02dc3ac | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.76e-04 | 175 | 36 | 3 | 6b4e841bde6cfa4956e1a0231672cea20f11210c | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.82e-04 | 176 | 36 | 3 | 8813c01ea080f373fe3970c5e1ba4c2dca0f7f02 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | 3.82e-04 | 176 | 36 | 3 | a40dfd8c4ba16757ff929b2f03a0628acf334de4 | |
| ToppCell | Dividing_Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 3.95e-04 | 178 | 36 | 3 | 1893fadac2ec3d5de0a641e57b7b2f962012a9ba | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.95e-04 | 178 | 36 | 3 | b1357ceb84b83fab53c0394c1af73cbd009f571a | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.01e-04 | 179 | 36 | 3 | 021d782134126c6f7dce6b6ea50cc54bdaa39987 | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.01e-04 | 179 | 36 | 3 | e67ad7ab04d0c1309296f57c1f53c5ca14c213fe | |
| ToppCell | 10x5'-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | 4.01e-04 | 179 | 36 | 3 | c93711273055a999335ba8d0f6500e4549f46cec | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.15e-04 | 181 | 36 | 3 | 0c5bc1660b8fc1e905ab4230202862de5be46ebd | |
| ToppCell | IIH-cycling-|IIH / Condition, Cell_class and T cell subcluster | 4.15e-04 | 181 | 36 | 3 | 7f4fed9e296bc22cb5a1e6c8e3c4b641e97c3078 | |
| ToppCell | IIH-cycling|IIH / Condition, Cell_class and T cell subcluster | 4.15e-04 | 181 | 36 | 3 | ec3e782ce93dcfe1a54fb7284e4e39063614b0e2 | |
| ToppCell | Healthy_Control-Lymphoid-T-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.15e-04 | 181 | 36 | 3 | ac1ee313910c05b1b3cb497bae14565464919c21 | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.15e-04 | 181 | 36 | 3 | f83565f09dd971c5cad2704a4a86bca0accd955e | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 4.21e-04 | 182 | 36 | 3 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 4.28e-04 | 183 | 36 | 3 | a48a6313f2f144586951cece97ec31f6d72361df | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.28e-04 | 183 | 36 | 3 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | Control-T/NK-proliferating_T/NK|Control / Disease group,lineage and cell class (2021.01.30) | 4.28e-04 | 183 | 36 | 3 | e740f05536d1e4b2512811771928eb65f6696409 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.35e-04 | 184 | 36 | 3 | 8260e688ec42a1374727bc85dceb7edd19a8b662 | |
| ToppCell | Dividing_Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.35e-04 | 184 | 36 | 3 | f15ce786d25c6546804a6d1efcc2ad645f2ef54e | |
| ToppCell | URO-Lymphocyte-T_NK-T_NK_proliferative|URO / Disease, Lineage and Cell Type | 4.42e-04 | 185 | 36 | 3 | 0ae9c646679c69a553eda670aef0e0495feb0286 | |
| ToppCell | droplet|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-04 | 185 | 36 | 3 | 4c8a25f36cbf43fc78d38dfeb3f1cab160bb029d | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4/8-lo|blood / Manually curated celltypes from each tissue | 4.42e-04 | 185 | 36 | 3 | df85ff34b796b403f2d0741771e9592e03657f6a | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.42e-04 | 185 | 36 | 3 | 9d424a8608b339dd6129c58d87626678d4ec4af7 | |
| ToppCell | COVID-cycling-|COVID / Condition, Cell_class and T cell subcluster | 4.42e-04 | 185 | 36 | 3 | eb74b8d36f7b749e04bc2ed4b36f7e1ac7bb6d5f | |
| ToppCell | COVID-cycling|COVID / Condition, Cell_class and T cell subcluster | 4.42e-04 | 185 | 36 | 3 | 5112f966735fa48f0606adcfd5c0212ad5d3d77a | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4|Lung / Manually curated celltypes from each tissue | 4.49e-04 | 186 | 36 | 3 | c67f373ba60e8d1ab70dfacc711ee440eaff6fb3 | |
| ToppCell | Dividing_Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.49e-04 | 186 | 36 | 3 | 0067eb78d4c7e32b9563550d9fcaf13445ee6a48 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-04 | 186 | 36 | 3 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-04 | 186 | 36 | 3 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.49e-04 | 186 | 36 | 3 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | COVID-19_Mild-Neu_4|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 4.56e-04 | 187 | 36 | 3 | 714851e757c71c559ee6413a3f61d6c117c79ad2 | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-Cycling_NK|Liver / Manually curated celltypes from each tissue | 4.63e-04 | 188 | 36 | 3 | 5eb94e652a734c6f15c68a178e9d05f0febcf34c | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4/8-lo-Cycling_T|blood / Manually curated celltypes from each tissue | 4.63e-04 | 188 | 36 | 3 | 714ccbcf826f26d39757931a3b8abbd952f4cddc | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.63e-04 | 188 | 36 | 3 | f5102e8d95506c25c675094b86162a6a50087b64 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative|Multiple_Sclerosis / Disease, Lineage and Cell Type | 4.63e-04 | 188 | 36 | 3 | 6c05797a5d0635d89ffcf4aca52178687129ccb4 | |
| ToppCell | normal-na-Lymphocytic-lymphocyte|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.70e-04 | 189 | 36 | 3 | b83fd81ecc5ef363be7435ee12cb7079e2434af7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.70e-04 | 189 | 36 | 3 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | normal-na-Lymphocytic|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.70e-04 | 189 | 36 | 3 | 1d382f8eb998c6a30e09fddc9a427afc8f5f7323 | |
| ToppCell | Dividing_Macrophages-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 4.70e-04 | 189 | 36 | 3 | d4e88a3e50499d683e3db38aee04490146fe30bb | |
| ToppCell | normal-na-Lymphocytic-lymphocyte-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.70e-04 | 189 | 36 | 3 | 3db4177d68cab4cd16842d2ebcaca28f69300e44 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.78e-04 | 190 | 36 | 3 | 2f54da2bee411f8868348a4c37034184b8f58a89 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.85e-04 | 191 | 36 | 3 | 588015d76b68488da6aa6603777682f3d81592bf | |
| ToppCell | facs-Tongue-nan-18m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-04 | 191 | 36 | 3 | 2e164d5a79ffbab93985be5bd8a513fdf597c673 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.85e-04 | 191 | 36 | 3 | a2c235a55094e4fd5273d764c9e2967116b48c23 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.85e-04 | 191 | 36 | 3 | 50854384fdaa0efa2e3227659d544ed09ac102f2 | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 4.85e-04 | 191 | 36 | 3 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 4.85e-04 | 191 | 36 | 3 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic-lymphocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.85e-04 | 191 | 36 | 3 | 56b45259dfc38bd5ea43b0e3adf47e7e2c043a5d | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 4.85e-04 | 191 | 36 | 3 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | (3)_Macrophage_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.85e-04 | 191 | 36 | 3 | b42f0b89bb94fd43786ff50f1caeb3ebfbbb43fd | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.85e-04 | 191 | 36 | 3 | 782bc7946417549ffd39e5b596db659436fa01ba | |
| ToppCell | facs-Skin-nan-18m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-04 | 192 | 36 | 3 | be4114b88a593e8bd905108dc603f62b16c5938b | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.92e-04 | 192 | 36 | 3 | f518839ecd9377537a414e8798766f7d91eafeac | |
| ToppCell | Dividing_Macrophages-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.92e-04 | 192 | 36 | 3 | 741bd0c2b0a7ce3fcb1610ce8bdacaf9a803c212 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_mem-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.92e-04 | 192 | 36 | 3 | 185dd150d3345cd29625052a46f3ed89f2a9a8f6 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 4.92e-04 | 192 | 36 | 3 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_TFH-like|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.00e-04 | 193 | 36 | 3 | 88cc740dd216ea80605b857c27914a8bc6ba6771 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 5.00e-04 | 193 | 36 | 3 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | control-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.00e-04 | 193 | 36 | 3 | ecb4018a47d9a82bb999e0bc8b3dceabd97d1f0d | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.00e-04 | 193 | 36 | 3 | ecbe1bd16df547427da5e69a3017300e766c2899 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.00e-04 | 193 | 36 | 3 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.08e-04 | 194 | 36 | 3 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.08e-04 | 194 | 36 | 3 | d852aebf7a763b9a776c4570711f0c759f591910 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.08e-04 | 194 | 36 | 3 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_mem|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.08e-04 | 194 | 36 | 3 | 40c7f9bd69a8e843b81972e25a67f591021415dd | |
| Disease | Congenital small ears | 6.96e-04 | 41 | 28 | 2 | C0152423 | |
| Disease | Ciliopathies | 4.89e-03 | 110 | 28 | 2 | C4277690 | |
| Disease | Polydactyly | 5.51e-03 | 117 | 28 | 2 | C0152427 | |
| Disease | bilirubin measurement | 8.28e-03 | 442 | 28 | 3 | EFO_0004570 | |
| Disease | emphysema imaging measurement | 8.45e-03 | 146 | 28 | 2 | EFO_0007626 | |
| Disease | complement factor H-related protein 3 measurement | 1.12e-02 | 169 | 28 | 2 | EFO_0600056 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KHKSKKKFKNPNNVL | 116 | Q86X53 | |
| NVLKKIKEKDKENKF | 351 | P49761 | |
| HKQKGKVKRKLKNQN | 466 | Q6UB98 | |
| IEQWHKKHKEKIKQK | 1091 | Q6UB98 | |
| QKKKKKKNNHIVAED | 596 | Q9P2D1 | |
| KKKQKVFQHNELKKE | 2591 | Q8IZT6 | |
| VKDQNKKVANLKHKE | 786 | Q8IUD2 | |
| KKVANLKHKEQVEKK | 791 | Q8IUD2 | |
| HEQKQQVVKFLIKKK | 281 | A5A3E0 | |
| KKEAFFKQKEKEKIN | 566 | Q49MG5 | |
| LKAQGKNKHFKVQLK | 321 | P16333 | |
| FTQKNKKEKKNIVQH | 161 | Q9H501 | |
| NKIVEHQNLSKKKKK | 726 | Q9H501 | |
| LDNDLKQEKKKLHQK | 656 | Q86UK5 | |
| DDLNFFNQKKKKKKT | 71 | P20042 | |
| HEQKQQVVKFLIKKK | 281 | A0JP26 | |
| HEQKQQVVKFLIKKK | 281 | Q6S8J3 | |
| QKQKSTLKNEKHLKK | 691 | Q8NFC6 | |
| KHKEWVQKKNEQKRK | 191 | Q96HJ3 | |
| KKNVKLQELINHKKA | 311 | Q8NHQ1 | |
| TKFKKEKNNKNKEAH | 1121 | Q16760 | |
| KQVSQKKKQKNGKKH | 91 | Q07325 | |
| QKLKHEKKVKKLQTD | 156 | P0DO97 | |
| KKALQQKDIHKKIKQ | 271 | Q6SJ93 | |
| VQNKQKEHKETAKKK | 266 | Q9UHY8 | |
| HEQKQQVVKFLIKKK | 281 | B2RU33 | |
| HEQKQQVVKFLIKKK | 281 | Q86YR6 | |
| KQIEKKEKKLHKIQN | 396 | Q5H9L4 | |
| KEKKLHKIQNKAQRQ | 401 | Q5H9L4 | |
| HLKKQQKELNSLKKK | 931 | Q15147 | |
| HEQKQQVVKFLIKKK | 281 | P0CG38 | |
| DVKANKHQIKQAVKK | 101 | P62750 | |
| KGHNLLKKKEEKLNQ | 1181 | Q9UPV0 | |
| AVKNFLVHKKNKKVE | 441 | Q13009 | |
| KDKKIITNHQKKNLF | 921 | Q9BX26 | |
| IKQNKKIKDKHLEQA | 126 | Q9Y2H8 | |
| HEQKQQVVKFLIKKK | 281 | Q6S5H5 | |
| HEQKQQVVKFLIKKK | 281 | A6NI47 | |
| DKAFKQKQKEEQKKL | 26 | Q9Y2S6 | |
| AHKQEKKEKLKNEKA | 31 | Q96EY4 |